ProfileGDS5822 / ILMN_2451441
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 82% 77% 75% 82% 77% 74% 73% 80% 76% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1170.682
GSM1276600PDAC Late Ablation Control 2107.277
GSM1276601PDAC Late Ablation Control 3122.475
GSM1276602PDAC Late Ablation 1167.582
GSM1276603PDAC Late Ablation 211677
GSM1276604PDAC Late Ablation 381.874
GSM1303940PDAC Late Ablation_anti-CTLA4 161.273
GSM1303941PDAC Late Ablation_anti-CTLA4 2177.980
GSM1303942PDAC Late Ablation_anti-CTLA4 3128.976